News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Gustavo Viani summarising the RAPIDO trial
Photo of Gustavo Viani from onconews.com.br
Aug 20, 2024, 14:45

Gustavo Viani summarising the RAPIDO trial

Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo, recently posted on X:

“ 2 CTH cycles less do not compromise the results with an increase CR-R:RAPIDO trial!

Methods: 

  • high-risk locally advanced rectal cancer (LARC).
  • Study design: Prospective observational cohort study.
  • Treatment: Short-course leading to 4 CAPOX or 6 FOLFOX leading to mesorectal excision or watch-and-wait (W and W) for clinical complete response (cCR).
  • Complete response (CR), locoregional recurrences, neurotoxicity.

Outcomes:

  • CR rate: RAPIDO trial (24%).
  • LRR: decreased (around 5-6%).
  • Neurotoxicity: less than RAPIDO trial.”

Gustavo Viani

Source: Gustavo Viani/X

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US).

Authors: Bengt Glimelius, Tanweer Khan, Karin Adolfsson, Eva Angenete, Åke Berglund, Kristina Bonde, Nils Elander, Tone Fokstuen, Johan Haux, Israa Imam, Cecilia Lagerbäck, Ingrid Ljuslinder, Andrzej Piwowar, Marie Zajicova, and Per J. Nilsson.

Gustavo Viani

 

 

Åke Berglund Andrzej Piwowar Bengt Glimelius cancer CAPOX Cecilia Lagerbäck clinical complete response Eva Angenete FOLFOX Gustavo Viani Ingrid Ljuslinder Israa Imam Johan Haux Karin Adolfsson Kristina Bonde LARC locally advanced rectal cancer Marie Zajicova Nils Elander OncoDaily Oncology Per J. Nilsson RAPIDO trial Tanweer Khan Tone Fokstuen
Special Coverage
Blog
Nov 21, 2024, 10:02
Staying current on cutting edge research into genetic/familial high-risk assessment - NCCN
Blog
Nov 21, 2024, 09:55
New Hope for Mantle Cell Lymphoma Patients - The Babak Lab
Blog
Nov 21, 2024, 09:28
Championing Children’s Health event at the European Parliament! - SIOP Europe
Blog
Nov 21, 2024, 09:23
Sachin H. Jain: Timeless lessons my father taught me about healthcare
Positive
Nov 21, 2024, 09:18
Vivek Subbiah: Delighted to welcome Krish Patel as our new lymphoma leader SCRI
Blog
Nov 21, 2024, 09:04
Tracey O'Brien: Lung cancer doesn’t discriminate
Blog
Nov 21, 2024, 06:52
Sylvester’s third annual Art is Medicine exhibit's new theme is "The Bridge to Bahia"
Blog
Nov 21, 2024, 06:49
OncoInfluencers to Follow on Social Media: Dr. Melvin L.K. Chua
Blog
Nov 21, 2024, 06:44
Hedley Lewis: Gratitude to all The Cows who participated in the Virgin Active South Africa Ride Joburg
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024